Keywords: endo, submits, frova, snda, menstrual, migraine, usa

Endo submits Frova US sNDA for menstrual migraine

Article | 31 July 2006

Print This

The USA's Endo Pharmaceuticals has submitted a supplemental New Drug Application to the Food and Drug Administration for Frova (frovatriptan ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in